Tibor Kempf

10.7k citations

104 papers · 8.1k indexed · 3 hit papers · h-index 49

Impact in

Rheumatology top 0.05%
- GDF15 and Related Biomarkers
Immunology top 0.5%
- Macrophage Migration Inhibitory Factor

Papers in

Rheumatology 51
- GDF15 and Related Biomarkers 51
Cardiology and Cardiovascular Medicine 44
- Heart Failure Treatment and Management 17
- Cardiac Fibrosis and Remodeling 10
- Cardiac Valve Diseases and Treatments 8

Co-authors: Kai C. Wollert Lars Wallentin Helmut Drexler Timo Peter Tim Allhoff Bertil Lindahl Christian Widera Johann Bauersachs
Journals: Clinical Chemistry (10 papers)European Heart Journal (9 papers)Circulation (6 papers)European Journal of Heart Failure (4 papers)International Journal of Cardiology (3 papers)
Partner nations: Germany United States Sweden

In The Last Decade

Tibor Kempf

101 papers receiving 8.0k citations

Hit Papers

align trajectories log scale

Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease 2016 · 411 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Clinical Chemistry
2012 Circulation
2006 Circulation Research

Peers

Countries citing papers authored by Tibor Kempf

Since Specialization

Citations

This map shows the geographic impact of Tibor Kempf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tibor Kempf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tibor Kempf more than expected).

Fields of papers citing papers by Tibor Kempf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tibor Kempf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tibor Kempf. The network helps show where Tibor Kempf may publish in the future.

Co-authors

The 25 scholars most cited alongside Tibor Kempf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tibor Kempf Line = papers co-authored together Tibor Kempf links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Anterior mitral leaflet laceration using the MitraCut technique for transapical transcatheter Tendyne implantation after unsuccessful Carillon indirect annuloplasty: a case report European Heart Journal - Case Reports ·Nunzio Davide de Manna, Andreas Martens, Marieke Jüttner, Dominik Berliner, Johann Bauersachs, Arjang Ruhparwar, Tibor Kempf, F. Ius	2024	1
2	Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment Clinical Research in Cardiology ·Stephan von Haehling, Birgit Aßmus, Tarek Bekfani, Elke Dworatzek, Frank Edelmann, Djawid Hashemi, Kristian Hellenkamp, Tibor Kempf, Philipp Raake, Katharina Andrea Schütt, Rolf Wachter, P. Christian Schulze, Gerd Hasenfuß, Michael Böhm, Johann Bauersachs	2024	11
3	Pre-emptive iron supplementation prevents myocardial iron deficiency and attenuates adverse remodelling after myocardial infarction Cardiovascular Research ·Bomee Chung, Yong Wang, Moritz R. T. Thiel, Fatemeh Rostami, Anika Rogoll, Valentin G. Hirsch, Zulaikha Malik, Anne Bührke, Christian Bär, Michael Klintschar, Jan D. Schmitto, Carla Vogt, Christopher Werlein, Danny Jonigk, Johann Bauersachs, Kai C. Wollert, Tibor Kempf	2023	13
4	Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study Journal of Nuclear Medicine ·Johanna Diekmann, Jonas Neuser, Manuel Röhrich, Thorsten Derlin, Carolin Zwadlo, Tobias Koenig, Desiree Weiberg, Felix Jäckle, Tibor Kempf, Tobias L. Roß, Jochen Tillmanns, James T. Thackeray, Julian D. Widder, Uwe Haberkorn, Johann Bauersachs, Frank M. Bengel	2023	17
5	In vivo adenine base editing reverts C282Y and improves iron metabolism in hemochromatosis mice Nature Communications ·Alice Rovai, Bomee Chung, Qingluan Hu, Sebastian Hook, Qinggong Yuan, Tibor Kempf, Florian Schmidt, Dirk Grimm, Steven R. Talbot, Lars Steinbrück, Jasper Götting, Jens Bohne, Simon Krooss, Michael Ott	2022	10
6	Molecular Imaging of Myocardial Fibroblast Activation in Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation (TAVI) Nuklearmedizin - NuclearMedicine ·Johanna Diekmann, Julia Neuser, Theresa König, Thorsten Derlin, Carolin Zwadlo, Jochen Tillmanns, Dominik Berliner, Tibor Kempf, TL Ross, James T. Thackeray, Joachim Widder, Johann Bauersachs, Frank M. Bengel	2022	2
7	Advanced Preconditioning: Impella 5.5 Support for Decompensated Heart Failure Before Left Ventricular Assist Device Surgery Cardiovascular revascularization medicine ·Tobias König, Jasmin S. Hanke, Guenes Dogan, Tibor Kempf, Jan‐Thorben Sieweke, Andreas Schäfer, Johann Bauersachs, Jan D. Schmitto, L. Christian Napp	2020	5
8	Cardiac Iron Concentration in Relation to Systemic Iron Status and Disease Severity in Non-Ischaemic Heart Failure with Reduced Ejection Fraction European Journal of Heart Failure ·Valentin G. Hirsch, Jörn Tongers, Julia Bode, Dominik Berliner, Julian D. Widder, Felicitas Escher, Vitalii Mutsenko, Bomee Chung, Fatemeh Rostami, Anja Guba‐Quint, Evangelos Giannitsis, Heinz‐Peter Schultheiß, Carla Vogt, Johann Bauersachs, Kai C. Wollert, Tibor Kempf	2020	36
9	One-year outcomes with the HeartMate 3 left ventricular assist device Journal of Thoracic and Cardiovascular Surgery ·Jasmin S. Hanke, Güneş Doğan, Amelie Zoch, Marcel Ricklefs, Leonhard Wert, Christina Feldmann, Christoph Bara, Malakh Shrestha, Jochen Tillmanns, Tibor Kempf, Johann Bauersachs, Axel Haverich, Jan D. Schmitto	2018	26
10	Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients Clinical Research in Cardiology ·Christoph Sinning, Francisco Ojeda, Philipp S. Wild, Renate B. Schnabel, Michael Schwarzl, Sevenai Ohdah, Karl J. Lackner, Norbert Pfeiffer, Matthias Michal, Maria Blettner, Thomas Münzel, Tibor Kempf, Kai C. Wollert, Kari Kuulasmaa, Stefan Blankenberg, Veikko Salomaa, Dirk Westermann, Tanja Zeller	2016	13
11	Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla® Flex II Occluder BMC Cardiovascular Disorders ·Jonas Neuser, Muharrem Akin, Udo Bavendiek, Tibor Kempf, Johann Bauersachs, Julian D. Widder	2016	7
12	Biomarkers for characterization of heart failure – Distinction of heart failure with preserved and reduced ejection fraction International Journal of Cardiology ·Christoph Sinning, Tibor Kempf, Michael Schwarzl, Simon Lanfermann, Francisco Ojeda, Renate B. Schnabel, Elvin Zengin, Philipp S. Wild, K Lackner, Thomas Münzel, Stefan Blankenberg, Kai C. Wollert, Tanja Zeller, Dirk Westermann	2016	55
13	Circulating concentrations of fibroblast activation protein α in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA International Journal of Cardiology ·Jochen Tillmanns, Christian Widera, Yasmin Habbaba, Paolo Galuppo, Tibor Kempf, Kai C. Wollert, Johann Bauersachs	2013	31
14	Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome Journal of Molecular and Cellular Cardiology ·Christian Widera, Shashi Kumar Gupta, Johan M. Lorenzen, Claudia Bang, Johann Bauersachs, Kerstin Bethmann, Tibor Kempf, Kai C. Wollert, Thomas Thum	2011	320
15	Multiple marker approach to risk stratification in patients with stable coronary artery disease European Heart Journal ·Renate B. Schnabel, Andreas Schulz, Claudia‐Martina Messow, Edith Lubos, Philipp S. Wild, Tanja Zeller, Christoph Sinning, Hans J. Rupprecht, Christoph Bickel, D Peetz, François Cambien, Tibor Kempf, Kai C. Wollert, Emelia J. Benjamin, Karl J. Lackner, Thomas F. Münzel, Laurence Tiret, Ramachandran S. Vasan, Stefan Blankenberg	2010	85
16	Growth-Differentiation Factor-15 in Heart Failure Heart Failure Clinics ·Tibor Kempf, Kai C. Wollert	2009	66
17	Growth Differentiation Factor-15 in Idiopathic Pulmonary Arterial Hypertension American Journal of Respiratory and Critical Care Medicine ·Nils Nickel, Tibor Kempf, Heike Tapken, Jörn Tongers, Florian Laenger, Ulrich Lehmann, Heiko Golpon, Karen M. Olsson, Martin R. Wilkins, J. Simon R. Gibbs, Marius M. Hoeper, Kai C. Wollert	2008	113
18	Growth Differentiation Factor-15 for Prognostic Assessment of Patients with Acute Pulmonary Embolism American Journal of Respiratory and Critical Care Medicine ·Mareike Lankeit, Tibor Kempf, Claudia Dellas, Mayumi Cuny, Heike Tapken, Timo Peter, Manfred Olschewski, Stavros Konstantinides, Kai C. Wollert	2008	135
19	Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction European Heart Journal ·Tibor Kempf, E. Bjorklund, S.‐O. Olofsson, Bertil Lindahl, Tim Allhoff, Timo Peter, Jörn Tongers, Kai C. Wollert, Lars Wallentin	2007	189
20	Anti-Inflammatory Treatment with Standardized Human Serum Protein Solution Reduces Local and Systemic Inflammatory Response after Hemorrhagic Shock European Surgical Research ·Michael Lauterbach, Georg Horstick, Tibor Kempf, L. S. Weilemann, Thomas Münzel, Oliver Kempski	2006	3

About Tibor Kempf

Tibor Kempf is a scholar working on Rheumatology, Cardiology and Cardiovascular Medicine, Physiology, Immunology and Critical Care and Intensive Care Medicine, having authored 104 papers that have together received 8.1k indexed citations. Recurring topics across this work include GDF15 and Related Biomarkers (51 papers), Nutrition and Health in Aging (38 papers), Macrophage Migration Inhibitory Factor (25 papers), Heart Failure Treatment and Management (17 papers), Cardiac Fibrosis and Remodeling (10 papers), Cardiac Valve Diseases and Treatments (8 papers), Apelin-related biomedical research (7 papers) and Cardiac Structural Anomalies and Repair (7 papers). The work is most often cited by research in Rheumatology (4.2k citations), Immunology (2.9k citations), Cardiology and Cardiovascular Medicine (3.0k citations), Physiology (3.1k citations) and Internal Medicine (148 citations). Tibor Kempf has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Kai C. Wollert, Lars Wallentin, Helmut Drexler, Timo Peter, Tim Allhoff, Bertil Lindahl, Christian Widera, Johann Bauersachs, Jörn Tongers and Mortimer Korf‐Klingebiel. Their work appears in journals such as Clinical Chemistry, European Heart Journal, Circulation, European Journal of Heart Failure and International Journal of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact